Amarin Corp Plc (AMRN)

[ralphey]

RESPECT-EPA sort of reminds me of Rodney Dangerfield


Results found the primary endpoint was the same across the EPA and control groups at two years follow-up (4.7%), with a slight variation in favor of EPA at four years (8.6% vs. 8.8%), and a greater benefit with EPA at six years (10.9% vs. 14.9%). Similar results occurred with the secondary endpoint, with the greatest difference occurring at six years (8.0% in the EPA group vs. 11.3% with the control group). There was no significant difference in all-cause mortality between the two groups and only a slight significant different in cardiovascular mortality at six years post-randomization between the EPA (2.0%) and control (3.0%) groups.